Peptides in urology and sexual medicine: clinical effectiveness, dosing, indications, and safety: a narrative review.
INTRODUCTION: Peptide-based therapies are increasingly used in urology and sexual medicine, although adoption is often influenced by off-label prescribing, direct-to-consumer promotion, and limited long-term safety…
Tesamorelin reduced belly fat in people with HIV and fat changes
Four trials with 909 people found tesamorelin lowered belly fat and waist size. Long-term safety and how long the benefit lasts are still unclear.
Study plan tests a drug plus exercise for physical strength in older adults with HIV
This paper describes the plan for a trial, not its results. It does not yet tell us whether the drug and exercise help.
The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration.
Performance-enhancing drugs (PEDs) marketed as "research compounds" include unregulated peptides intended to modulate the growth hormone-insulin-like growth factor-1 (GH-IGF-1) axis.
The effect of growth hormone-releasing hormone on cognition and brain connectivity in adults with cognition ranging from normal to mild cognitive impairment.
Cognitive decline with age and other clinical conditions are linked with reduced hypothalamic-pituitary-adrenal (HPA) axis function.